Enhanced Identification of Postoperative Infections among Inpatients
Deborah S. Yokoe*
, Gary A. Noskin†, Susan M. Cunningham†, Gianna Zuccotti‡, Theresa Plaskett‡, Victoria J. Fraser§, Margaret A. Olsen§, Jerome I. Tokars¶, Steven Solomon¶, Trish M. Perl#, Sara E. Cosgrove#, Richard S. Tilson*, Maurice Greenbaum**, David C. Hooper††, Kenneth E. Sands‡‡, John Tully§§, Loreen A. Herwaldt¶¶, Daniel J. Diekema¶¶, Edward S. Wong##, Michael Climo##, and Richard Platt***
Author affiliations: *Brigham and Women's Hospital, Boston, Massachusetts, USA; †Northwestern University, Chicago, Illinois, USA; ‡Memorial Sloan-Kettering Cancer Center, New York, New York, USA; §Washington University School of Medicine, St. Louis, Missouri, USA; ¶Centers for Disease Control and Prevention, Atlanta, Georgia, USA; #Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; **North Shore Medical Center-Salem Hospital, Salem, Massachusetts, USA; ††Massachusetts General Hospital, Boston, Massachusetts, USA; ‡‡Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; §§Mount Auburn Medical Center, Cambridge, Massachusetts, USA; ¶¶University of Iowa Carver College of Medicine, Iowa City, Iowa, USA; ##McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA; ***Harvard Pilgrim Health Care, Boston, Massachusetts, USA
Main Article
Table 4
Percentage of patients who met the antimicrobial drug, diagnosis code–screening criteria, or both, after CABG procedures, cesarean delivery, and breast proceduresa
Procedure and phase |
% of patients meeting
|
Antimicrobial exposure criteria |
Diagnosis code criteria |
Antimicrobial exposure
or diagnosis code criteria |
CABG |
Phase 1 |
15.2 |
4.5 |
15.8 |
Phase 2 |
19.1 |
4.6 |
19.6 |
Cesarean delivery |
Phase 1 |
8.8 |
3.2 |
9.5 |
Phase 2 |
12.7 |
6.4 |
14.1 |
Breast procedures |
Phase 1 |
3.5 |
0.8 |
3.7 |
Phase 2 |
6.7 |
2.0 |
6.8 |
Main Article
Page created: April 17, 2012
Page updated: April 17, 2012
Page reviewed: April 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.